Blog
RSS FeedPosted by Michael Wonder on 24 Jul 2017
Companies rush to develop ‘utterly transformative’ gene therapies
23 July 2017 - The approval of gene therapy for leukaemia, expected in the next few months, will open the ...
Posted by Michael Wonder on 23 Jul 2017
Tackling submission and publication bias
17 July 2017 - Evoniuk and colleagues analysed whether submission and publication bias are based on study outcome. ...
Posted by Michael Wonder on 20 Jul 2017
EU watchdog concerned drug agency EMA may be too close to companies
19 July 2017 - The EMA, eager to accelerate access to promising new drugs, may be getting too cosy with ...
Posted by Michael Wonder on 13 Jul 2017
AusBiotech welcomes industry nominee to PBAC
13 July 2017 - AusBiotech has today welcomed the appointment of industry nominee Michelle Burke to the PBAC, who is ...
Posted by Michael Wonder on 13 Jul 2017
PBAC announces appointment of industry expert to Committee
13 July 2017 - Medicines Australia is pleased to welcome the appointment of Michelle Burke to the PBAC. ...
Posted by Michael Wonder on 12 Jul 2017
FDA collaborates to promote safety, quality in clinical trials done in India
12 July 2017 - After more than 16 hours of travel, we touch down in Mumbai late in the evening ...
Posted by Michael Wonder on 10 Jul 2017
Considering the side effects of drug makers’ money back guarantees
10 July 2017 - More than a decade ago, Italy tried a novel approach to help bring down drug costs: ...
Posted by Michael Wonder on 06 Jul 2017
Brexit must not disrupt drug R&D, say pharma chiefs
6 July 2017 - Industry lobbying began shortly after British referendum last June. ...
Posted by Michael Wonder on 03 Jul 2017
SMC industry engagement event
3 July 2017 - The SMC has announced details of the next Scottish Medicines Consortium Industry Engagement Event. ...
Posted by Michael Wonder on 03 Jul 2017
Supreme Court hands patent win to pharmaceutical companies
30 June 2017 - Canada’s Supreme Court on Friday struck down rules making it easy for generic drug firms to ...
Posted by Michael Wonder on 02 Jul 2017
Fears over a medical gold rush in cancer drug race
3 July 2017 - With almost 800 trials under way observers warn scientific rigour is being compromised. ...
Posted by Michael Wonder on 27 Jun 2017
NICE launches a competition for developers of health care technologies
27 June 2017 - NICE Scientific Advice has launched a competition for small or medium sized companies, charities and academic research ...
Posted by Michael Wonder on 22 Jun 2017
Clinical trials provide $1.1b to Australian economy: MTPConnect releases report on clinical trials ecosystem in Australia
21 June 2017 - MTPConnect today released a new report ‘Clinical Trials in Australia: the economic profile and competitive position ...
Posted by Michael Wonder on 19 Jun 2017
Emerging use of early health technology assessment in medical product development: a scoping review of the literature
20 June 2017 - Early health technology assessment is increasingly being used to support health economic evidence development during early stages ...
Posted by Michael Wonder on 15 Jun 2017
Fostering medical innovation: a plan for digital health devices
15 June 2017 - It is incumbent upon FDA to ensure that we have the right policies in place to promote ...